No more carrier "black boxes": just clear, actionable data
commercials feature actors who are proud of themselves when they take just one non-steroidal anti-inflammatory pain killer in the morning and not again until the end of the day
This meta-analysis evaluates their effects on mortality and hospitalization in HFpEF
Naur P, Hansen KB, Kristensen AS, Dravid SM, Pickering DS, Olsen L, et al
Toward More Tailored Dosing Strategies While the panacea of individualised dosing regimens might represent a leap too far in terms of complexity, the opportunity does exist for pharmaceutical companies to implement a more tailored approach when it comes to dosing, arriving at a more delicate balance of drug exposure, bioavailability, efficacy and safety based on the characteristics of certain patient cohorts